Variant ID: 2-113532647-C-A


This variant was identified in 1 publication


Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
I Makhoul, VK Todorova, ER Siegel, SW Erickson, I Dhakal, VR Raj, JY Lee, MS Orloff, RJ Griffin, RS Henry-Tillman, S Klimberg, LF Hutchins, SA Kadlubar
Publication Date: 2017

Variant appearance in text: rs3783588
PubMed Link: 28045923
PubMed Central Link
Variant Present in the following documents:
  • pone.0168550.s006.xlsx
  • pone.0168550.s005.xlsx
  • pone.0168550.s007.xlsx
View BVdb publication page

Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000263339.3 c.813G>T p.Ala271= synonymous_variant 7/7 -
NM_000575.5 c.813G>T p.Ala271= synonymous_variant 7/7 -
NM_001371554.1 c.813G>T p.Ala271= synonymous_variant 7/7 -